Cholesterol, Hypertension, and Stress
(READING TIPS: For fast reading, scan through the topic headings in BOLD BLACK, important conclusions in BOLD BLUE, and " Must Know " in BOLD RED. To jump to specific sections in this article, click on the respective LINKS in the Contents.)
| Before You Begin Information presented here is for general educational purposes only. Each one of us is biochemically and metabolically different. If you have a specific health concern and wish my personalized nutritional recommendation, write to me by clicking here. |
Content
Introduction
Elevated Cholesterol
Elevated Blood Pressure
Elevated Stress
Discussion
14 million Americans have heart disease and more than
2,600 die daily from heart attacks in the United States alone. According to the
World Health Organization, 12 million people worldwide die every year from heart
attacks, strokes, and other forms of cardiovascular diseases. 15% of adults in
their late 30s to 40s are afflicted by this disease, about 50% of 55 to 64 year-olds,
and 65% of those in the next decade are afflicted. It is obvious that most of
the population slept through Heart Disease Prevention 101 in school.
To reduce the incidences of cardiovascular disease, researchers have been unearthing
markers that have proven predictive values in this disease. Over 300 markers have
been unearthed, including correlations between infection, age and height, and
male pattern baldness to the increased incidence to cardiovascular disease.
What are the latest alternative treatment options in normalizing three established
risk factors - elevated cholesterol, hypertension, and stress?
Elevated Cholesterol
Cholesterol, a lipid (fatty) component of all cellular membranes, is required
to support cellular integrity and for the biosynthesis of vital hormones. 80%
of our cholesterol is produced by the liver. The endogenous production of cholesterol
is controlled by the rate limiting enzyme, HMG-CoA ( 3-hydroxy-3-methyglutaryl
coenzyme A) reductase.
Cardiovascular disease caused by atherosclerosis begins in our teenage years.
In response to the high cholesterol level, muscle cells underneath the endothelium,
or inner lining, of blood vessels release a signal to attract monocytes. Monocytes
are white blood cells that fight infection. When these cells migrate under the
endothelium and amass cholesterol, calcium, and other substances, a plaque is
formed. With time, the swollen endothelium loses its elasticity and may rupture.
This injury to the lining draws clot-forming platelets, resulting in a clot or
thrombus. The narrowed artery may cause chest pain (angina) or, if completely
obstructed, a heart attack.
Elevated serum cholesterol level is a recognized and well-established risk factor
for developing coronary heart disease. For most people, lifestyle adjustments
(including dietary changes and moderate exercise) are sufficient to normalize
the cholesterol levels. For those who don't respond to these methods, or for those
with a genetic predisposition to hypercholesterolemia, standard medical therapy
will employ drugs to bring cholesterol under control. These include bile acid
sequestrants, cholestyramine, and colestipol.
A class of drugs used to aggressively treat elevated LDL levels is the synthetically
derived HMG-CoA reductase inhibitors such as Iovastatin, pravastatin, and simvastatin.
By inhibiting the production of HMG-CoA reductase, cholesterol production in the
liver is reduced. Together, they belong to the "statin" group of drugs. These
are among the most potent lipid-lowering agents available. To compensate for the
resulting reduction of cholesterol production, the liver increases absorption
of LDL cholesterol, further contributing to an overall reduction of LDL cholesterol
levels.
While statin drugs are
effective in lowering LDL cholesterol, they have serious side effects.
Inhibition of HMG-CoA reductase also inhibits the intrinsic biosynthesis of Coenzyme
Q10 (CoQ10), a central compound in the mitochondrial respiratory chain. CoQ10
is indispensable for optimum cardiac function, and reduction of CoQ10 constitutes a new
risk of cardiac disease, especially for those whose cardiac function is compromised,
such as those with congestive heart failure or cardiomyopathy. Statin drugs are
also expensive to use with monthly costs around US $100-200.
To deal with the prohibitive cost of statins, researchers in China have examined
the use of a natural food product called red yeast rice as a more affordable alternative
to controlling cholesterol levels. Red yeast flour is used extensively in Chinese
cooking as a flavoring agent and food coloring for dishes such as tofu, Peking
duck, and Chinese spareribs. It is manufactured by fermenting rice with a specific
strain of yeast called Monascus purpureus. It has been used as health-enhancing
properties for over two thousand years. Only
recently was it discovered that red yeast rice contains an abundance of lovastatin,
the same cholesterol-lowering ingredient found in pharmaceutical statins, such
as Mevacor, that acts as HMG-CoA reductase inhibitors.
Clinical research has been conducted
in China and the United States. A single-blind trial with 502 patients diagnosed
with hyperlipidemia was studied in China. Patients were randomized into one of
four groups: three treatment groups and a control. These patients either had a
serum total cholesterol of over 230 mg/dL, LDL of at least 130 mg/dL, or triglyceride
of 200-400 mg/dL. All patients also had HDL levels lower than 44 mg/dL. Patients
were given 600 mg red yeast rice twice a day (1,200 mg/day). After 4 weeks of
therapy, the treatment group's LDL level declined an average of 24.6% versus only
6.3% in the control group. Serum triglyceride levels declined an average of 19.8%
in the treatment group versus 9.2% in controls. HDL levels increased by 12.8%
in the treatment versus only 4.9% in the control group, and total cholesterol
levels decreased significantly by 17.1% in the treatment group, compared to a
drop in the control group of only 4.8%. Benefits continued to accrue over the
course of the eight-week study, with patients in the treatment group achieving
an average reduction in total cholesterol of 22.7% versus a 7% average reduction
in the control group. LDL reduction was 30.9% in the treatment group, triglyceride
levels were reduced by 34% in the treatment group versus 13% in the control group,
and HDL increased by 20% versus only 8% in the control group.
A similar study over 12 weeks was carried out in America by Dr. David Herber of
the University of California at Los Angeles. Dr. Herber's study was a double-blind,
placebo-controlled experiment involving 83 volunteers taking red yeast supplements.
LDL levels dropped 15% among patients taking the red yeast supplement over an
eight-week period. Most individuals following a very strict diet - without taking
a cholesterol-lowering supplement - can only expect to have a 10% reduction in
cholesterol level.
While generally well tolerated, minor side effects of red yeast rice include heartburn,
flatulence and dizziness. These are usually resolved upon its discontinuation.
Nutritional Supplements Consideration:
- 600 mg Red Yeast Rice Powder twice a day for those with cholesterol levels greater
than 200 mg/dl and triglyceride levels greater than 200 mg/dL
Elevated Blood Pressure
Hypertension weakens the artery wall
which are already stiffened and narrowed by plaques. As the heart is overloaded,
blood pressure continues to rise. This increase forces the left ventricle of the
heart to work even harder, causing left ventricular hypertrophy, resulting in
chronic heart failure and electrical system dysfunctions, triggering arrhythmias.
Traditional treatment of hypertension varies from beta-blockers, vasodilators,
diuretics, and calcium channel blockers. They are prescribed under the supervision
of a physician and many have unpleasant side effects.
Alternative forms of treating hypertension through natural means have been under
study in recent years, especially in relation to minerals. Epidemiological data
suggest a relationship between blood pressure and calcium, potassium, and magnesium.
Relatively high amounts of mineral intake can induce vascular smooth muscle relaxation
and thus, peripheral resistance. These minerals are also critical in controlling
conduction system and reduce the incidence of arrhythmias. Magnesium, in particular,
plays a role in neuromuscular transmission activity and ion exchange. Studies
have shown that patients with essential hypertension have significantly lowered
blood pressure after 8 weeks on the mineral compared to the control group.
Other than minerals, essential fatty acids have anti-inflammation and platelet
aggregation, thereby lowering blood pressure. A high intake
of 5,000 mg to 10,000 mg of essential fatty acids is needed. This often
causes a harmless but unpleasant fishy "burp" which is not well tolerated. Also,
the herb hawthorne has been known to cause vasodilatation, which reduces peripheral
vascular resistance. It enhances cardiac ejection fraction and decreases blood
pressure.
Nutritional Supplements Consideration:
- Magnesium 400 - 700 mg
- Calcium 800 - 1,000 mg
- Potassium 400 - 600 mg (from food)
- Hawthorne 160 - 250 mg (2% flavonoids and 18.75% procyanidins)
Elevated Stress
Stress is a hallmark risk factor of
cardiovascular disease, mainly due to its effect on arterial blood pressure, levels
of atherosclerosis promoters, and neuroendocrine reactions.
Studies of psychological stress in monkeys, for example, demonstrated an increased
number of injured endothelial cells in the thoracic aorta. Acute psychological
stress has also been shown to induce rapid and significant elevation in plasma
homocysteine levels. The monkeys also suffered from exacerbated atherosclerosis
via a heightened response of the sympathetic nervous system, which also exacerbates
poor circulation. Studies have found that laboratory-induced stress, such as anger
and irritability in heart disease patients, causes ischemia more than half the
time.
Stress management can measurably improve performance on cardiac function tests.
This is especially true of Type A personalities, whose chances of developing heart
disease by the time they are 50 is four to five time greater than Type B personalities.
The writing on the wall is clear - relax or else!
Certain nutrients can reduce the effects of the stress response at the physiological
level. Antioxidant nutrients, such as Coenzyme Q10 (CoQ1O), Vitamin E, Vitamin
B complex, and Magnesium help counteract the increase in oxidative stress associated
with psychological stress.
Nutritional Supplements Consideration:
- Coenzyme Q10: 30 mg
- Vitamin E: 400 IU
- Vitamin B12: 500 - 1,000 mcg
- Magnesium: 300 - 500 mg
- Vitamin C: 500 - 2,000 mg
- Bea Carotene: 15,000 - 25,000 IU
| Attention Because of tremendous individual variation, the use of nutritionals should therefore be personalized for your body. One person’s nutrient can be another person’s toxin. If you have a specific health concern and wish my personalized nutritional recommendation, write to me by clicking here. |
| Message from Dr. Lam I hope you have enjoyed reading this article. If you have areas you don’t understand, comments (good or bad), or if you have a specific health concern, feel free to write to me by clicking here. |
About The Author
Michael Lam, M.D., M.P.H., A.B.A.A.M. is a specialist in Preventive and Anti-Aging Medicine. He is currently the Director of Medical Education at the Academy of Anti-Aging Research, U.S.A. He received his Bachelor of Science degree from Oregon State University, and his Doctor of Medicine degree from Loma Linda University School of Medicine, California. He also holds a Masters of Public Health degree and is Board Certification in Anti-aging Medicine by the American Board of Anti-Aging Medicine. Dr. Lam pioneered the formulation of the three clinical phases of aging as well as the concept of diagnosis and treatment of sub-clinical age related degenerative diseases to deter the aging process. Dr. Lam has been published extensively in this field. He is the author of The Five Proven Secrets to Longevity (available on-line). He also serves as editor of the Journal of Anti-Aging Research.
For More Information
For the latest anti-aging related health issues, visit Dr. Lam
at www.LamMD.com. Feel free to email
Dr. Lam at dr@LamMD.com if you have any questions.
Reprint Information
This article may, in its unabridged, unaltered form and in its entirety only,
be reprinted and republished without permission provided that it is for personal
and non commercial education use only and further provided that credit be given
to the author, with copyright notice and www.LamMD.com
clearly displayed as source. Written permission from Dr. Lam is required
for all other use.
©2000 Michael Lam, M.D. All Rights Reserved.
References
Cooney RV, Franke AA, Harwood P~J, et al: Gamma-tocopherol detoxification
of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sd 90:1771
- 1775, 1993.
English Jim. Lipid Lowering Effects of Red Yeast Rice Extract. Vitamin Research
Lab New 1999 Nov.
Folkers K, Langsjoen P, Willis R, Richardson P, Xia U, Ye CQ, Lovastatin decreases
coenzyme Q levels in human. Proc Natl Aced Sd USA 1990 Nov 87:22 8931-4.
Galland L: magnesium stress and neuropsychiatnc disorders. Magnes Trace EIem
10:287-301, 1991.
Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VU,. Cholesterol-lowering
effects of a proprietary Chinese red-yeast-rice dietary supplement. AM J C/in
Nutr 1999 Feb 69:2 231-6.
Heber D. Natural Remedies for a Healthy Heart. Garden City Park, NY: Avery;
1998.
Papas AM: Other antioxidants In: Antioxidant Status, Diet, Nutrition end Health.
New York: CRC Pr, 1999.
Reaven PD, Knouw A, Beltz WF, et al: Effect of dietary antioxidant combinations
in human: protection of LDL by vitamin E but not by beta-carotene. Arter Throm
13:590-600, 1993.
Rozanski A, Blumenthal JA, KaplanJ: Impact of psychological factors on the pathogenesis
of cardiovascular Disease and Implication for therapy. Circulation 99:2192-2217,
1999.
Stephens NG, Parson A, Schofield PM, et al: Randomised controlled trial of Vitamin
E in patients with coronary disease: Cambridge Heart Antioxidant Study. The
Lancet 347(9004): 781-786, 1996.